Amarantus signs cGMP manufacturing deal with Catalent
Biotechnology company Amarantus BioScience Holdings, Inc. has entered into a manufacturing agreement with Catalent Pharma Solutions for clinical-grade production of MANF (mesencephalic-astrocyte-derived neurotrophic factor).